About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Ptger2tm1.1Kand
targeted mutation 1.1, Katrin I Andreasson
MGI:5559328
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Ptger2tm1.1Kand/Ptger2tm1.1Kand
Tg(ITGAM-cre)2781Gkl/0
involves: C57BL/6 * CBA MGI:5559329


Genotype
MGI:5559329
cn1
Allelic
Composition
Ptger2tm1.1Kand/Ptger2tm1.1Kand
Tg(ITGAM-cre)2781Gkl/0
Genetic
Background
involves: C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptger2tm1.1Kand mutation (0 available); any Ptger2 mutation (31 available)
Tg(ITGAM-cre)2781Gkl mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• expression analysis suggests a decrease in the inflammatory and proliferative state of microglia
• expression analysis indicates a blunted systemic and brain innate immune response to systemic LPS treatment

homeostasis/metabolism
• decrease in the inflammatory response and microglial and astrocyte activation after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in the substantia nigra pars compacta
• however, no rescue of the loss of TH+ neurons in MPTP treated mice is detected
• increase in dopamine turnover in MPTP treated mutants compared to similarly treated controls

nervous system
• expression analysis suggests a decrease in the inflammatory and proliferative state of microglia

hematopoietic system
• expression analysis suggests a decrease in the inflammatory and proliferative state of microglia





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
06/12/2024
MGI 6.13
The Jackson Laboratory